Resmed Inc. buy Mizuho
Start price
26.01.24
/
50%
€175.35
Target price
26.01.25
€179.54
Performance (%)
35.33%
End price
27.01.25
€237.30
Summary
This prediction ended on 27.01.25 with a price of €237.30. The BUY prediction by Mizuho for Resmed Inc. saw massive gains of 35.33%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.412% | 0.412% | -0.102% |
| iShares Core DAX® | 0.231% | -2.413% | 15.337% |
| iShares Nasdaq 100 | 1.663% | -1.658% | 31.087% |
| iShares Nikkei 225® | -0.208% | -2.502% | 43.625% |
| iShares S&P 500 | 1.067% | -1.579% | 24.346% |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Mizuho from $180.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten